1. Skip to navigation
  2. Skip to content
PRWeb
  • Home
  • News Center
  • Blog
Login Create a free account
  • Front Page
  • Arts
  • Business
  • Education
  • Environment
  • Government
  • Industry
  • Lifestyle
  • Sports
  • Tech
  • More
    • Industry
    • Lifestyle
    • Sports
    • Tech
    • Automotive
    • Communiques
    • Computer
    • Events
    • Health
    • Home and Family
    • iReach Archive
    • Legal / Law
    • Media
    • Miscellaneous
    • Opinion / Editorial
    • Podcasting
    • Science
    • Society

RSS Email Newsletters Put PRWeb on your site

Showing 51 - 75
of 2500 results

PreviousNext
  • News Center
  • All Health
  • Pharmaceuticals
  • All Health
  • Abortion
  • Addiction
  • Allergies
  • Alternative Medicine
  • Asthma
  • Cancer
  • Cardiology
  • Chiropractic
  • Dental
  • Dermatology
  • Diabetes
  • Emergency
  • Family Medicine
  • General
  • Geriatrics
  • Hospitals
  • Infectious Diseases
  • Internal Medicine
  • Managed Care / HMO
  • Medical Products
  • Mental Health
  • Neurology
  • Nursing
  • Nutrition
  • OB / GYN
  • Occupational Safety
  • Pediatrics
  • Pharmaceuticals
  • Physical Therapy
  • Plastic Surgery
  • Psychology
  • Radiology / Imaging
  • Research
  • Sports Medicine
  • Surgery
  • Veterinary
  • Vision

View all releases by:

  • MSA (region)
  • Day
  • Video releases

Morehouse School of Medicine’s "Danforth Dialogues" Features Renowned NIH Research Scientist Dr. Barney Graham

February 10, 2023MSM President and CEO Dr. Valerie Montgomery Rice and Dr. Graham reveal the fascinating journey behind the development of the COVID-19 Vaccine

Draper’s Kidney-on-a-chip Study Offers Clues for Developing Drugs with Fewer Side Effects

Draper’s Kidney-on-a-chip Study Offers Clues for Developing Drugs with Fewer Side EffectsFebruary 09, 2023Draper tested kidney-chips in its latest research study. Scientists may be able to use the findings to develop drugs with...

New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial

February 09, 2023Notalgia paresthet​ica—a nerve disorder character​ized by a persistent itch in the upper back—is a common and underdiag​nosed condition worldwide. To date, there are no FDA-approved treatments specifically targeting...

NACDS Statement in Response to State of the Union Address

February 08, 2023National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson issued two statements on Tuesday night in relation to President Biden’s State of the Union Address.

Rx relief® Receives 2023 Best of Staffing® Employee Award

Rx relief® Receives 2023 Best of Staffing® Employee AwardFebruary 07, 2023Rx relief is pleased to announce that it has earned ClearlyRa​ted's Best of Staffing® Employee Award for providing...

Rx Relief® Wins 2023 Best of Staffing® Client and Talent 10-Year Diamond Awards

Rx Relief® Wins 2023 Best of Staffing® Client and Talent 10-Year Diamond AwardsFebruary 07, 2023Rx relief, a division of The PrideStaff Companies, is pleased to announce that it has earned ClearlyRa​ted’s Best of...

Rising Inflation Leads to Growing Pet Owner Concerns, and Neogen Takes Steps to Provide Relief

Rising Inflation Leads to Growing Pet Owner Concerns, and Neogen Takes Steps to Provide ReliefFebruary 07, 2023Recognizing the escalating need for quality care products at an affordable price, Neogen launches Initiative and partners...

BioPlus Specialty Pharmacy Earns a Spot on Forbes Health’s ‘Best Online Pharmacies’ List

February 07, 2023Patients and their healthcare providers benefit from access to top-rated specialty pharmacy care from BioPlus, according to a new ranking of online pharmacies.

NLP Leader Huma.AI Launches Industry's First Generative AI Platform for Life Sciences

NLP Leader Huma.AI Launches Industry's First Generative AI Platform for Life SciencesFebruary 06, 2023Enterprise Generative AI Focused on Life Sciences to Bring Life-Saving Drugs to Market Faster

Farlong Nutraceutical Concludes 90-Day Clinical Study to Determine Safety and Efficacy of Cognitive Health Supplement, Farlong Lifeflower® Breviscapine

Farlong Nutraceutical Concludes 90-Day Clinical Study to Determine Safety and Efficacy of Cognitive Health Supplement, Farlong Lifeflower® BreviscapineFebruary 02, 2023Peer-revi​ewed results demonstrated positive impact on brain health and function

RapidScreen Named Exclusive Reseller in Canada for Lucira’s PCR-Quality Check-IT and COVID-19 & Flu At-Home Molecular Tests

RapidScreen Named Exclusive Reseller in Canada for Lucira’s PCR-Quality Check-IT and COVID-19 & Flu At-Home Molecular TestsFebruary 02, 2023Developed by Lucira Health Inc., both the COVID-19 test and COVID-19 and Flu combination test are highly accurate, authorize​d...

Super Aging: Ingredients for Living Well as Long as Possible, Upcoming Webinar Hosted by Xtalks

Super Aging: Ingredients for Living Well as Long as Possible, Upcoming Webinar Hosted by XtalksFebruary 02, 2023This free webinar will discuss the top ingredients and current research on super aging. Attendees will understand the...

Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval

February 01, 2023The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenop​ausal women...

MotherToBaby Launches First Lupus in Pregnancy Research Study

MotherToBaby Launches First Lupus in Pregnancy Research StudyFebruary 01, 2023World-Ren​owned UC San Diego Epidemiol​ogist Leads Groundbre​aking Study

Breaking Down Barriers in Support of Patients with Rare Diseases, Upcoming Webinar Hosted by Xtalks

Breaking Down Barriers in Support of Patients with Rare Diseases, Upcoming Webinar Hosted by XtalksFebruary 01, 2023In this free webinar, gain insights into global regulatory strategy and operational execution in rare disease clinical...

NCPDP Announces Admiral Brett Giroir, M.D., as Opening Keynote Speaker for Its 2023 Annual Technology & Business Conference

NCPDP Announces Admiral Brett Giroir, M.D., as Opening Keynote Speaker for Its  2023 Annual Technology & Business ConferenceJanuary 31, 202316th HHS Assistant Secretary for Health, Dr. Giroir, Will Engage and Inspire Conference Goers in a Powerful Call to Action to...

University of Medicine and Health Sciences Presents “Medical Specialty Spotlight: What is an Anesthesiologist?”

University of Medicine and Health Sciences Presents “Medical Specialty Spotlight: What is an Anesthesiologist?”January 31, 2023Top-rated Caribbean Med School Hosts Panel Discussion Focused on Career Opportuni​ties For Future Doctors

Apex Trials Joins hyperCORE International’s Clinical Trial Network

Apex Trials Joins hyperCORE International’s Clinical Trial NetworkJanuary 30, 2023hyperCORE Internati​onal has welcomed Apex Trials to its super network of clinical trial sites. Apex Trials is based in a...

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral Palsy

NeuroCytonix Completes Clinical Trial of its NeuroCytotron Treatment of Cerebral PalsyJanuary 30, 2023The NeuroCyto​tron utilizes non-invas​ive, safe, tissue engineering technology that stimulates proteins which aid in the...

Right at Home Agencies Earn National Recognition With 2023 Best of Home Care Awards

January 27, 2023Right at Home is excited to announce that 249 locations were nationally recognized with multiple 2023 Best of Home Care Awards from Home Care Pulse.

AvevoRx ANNOUNCES ENTRY INTO ALPHA-1 PROTEINAISE INHIBITOR MARKET, INCREASING THERAPEUTIC ACCESS FOR PATIENTS WITH RARE FORM OF CONGENITAL EMPHYSEMA

January 27, 2023Alpha-1 joins AvevoRx’s growing suite of specialty infusion therapy offerings and its portfolio of in-home ambulatory infusion suites

Wellness Coaches Continues Investment in Clinical Services with Latest Acquisition

January 26, 2023Wellness Coaches, a leading national provider of clinical and wellbeing solutions, is pleased to announce the acquisition of Corporate Health Solutions (CHS).

Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium

January 26, 2023Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercia​l-scale plasmid DNA (pDNA) manufactu​ring facility at its...

Life Molecular Imaging and Advanced Medical Support Announce Partnership for the Production of Florbetaben (18F) at the American University of Beirut Medical Centre

Life Molecular Imaging and Advanced Medical Support Announce Partnership for the Production of Florbetaben (18F) at the American University of Beirut Medical CentreJanuary 26, 2023Improved supply capabilities of Florbetaben (18F) to provide access to Amyloid-PET to patients throughout the MENA region

CS Analytical Expands Service Offering for New USP 382 Testing Requirements

CS Analytical Expands Service Offering for New USP 382 Testing RequirementsJanuary 25, 2023With our unique focus on container and package system testing, expanding our service offering to directly address all aspects...

Showing 51 - 75
of 2500 results

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...100
PreviousNext
  • News Center
  • All Health
  • Pharmaceuticals
PRWeb

Questions about a news article you've read?

Reach out to the author: contact and available social following information is listed in the top-right of all news releases.

Questions about your PRWeb account or interested in learning more about our news services?

Call PRWeb:1-866-640-6397

  • PRWeb home
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Learning
  • Blog
  • About Cision
  • Contact Us
  • Partners
  • Subscribe to News
  • Terms of Service
  • Privacy Policy
  • Copyright
  • Site Map
Best SearchUpshot 50
Create a free prweb account
Cision logo

©Copyright 1997-2015, Vocus PRW Holdings, LLC. Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.